Np mrd loader

Record Information
Version1.0
Created at2022-09-04 02:11:41 UTC
Updated at2022-09-04 02:11:41 UTC
NP-MRD IDNP0186364
Secondary Accession NumbersNone
Natural Product Identification
Common Name[(2s,3r,4r,5s)-5-{[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-6-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-3-yl]oxy}-3,4-dihydroxyoxolan-2-yl]methyl acetate
DescriptionCissoside III belongs to the class of organic compounds known as flavonoid-3-o-glycosides. These are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C3-position. It was first documented in 2022 (PMID: 36057789). Based on a literature review a significant number of articles have been published on Cissoside III (PMID: 36057448) (PMID: 36057421) (PMID: 36057440) (PMID: 36057753) (PMID: 36057616) (PMID: 36057549).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC28H30O16
Average Mass622.5320 Da
Monoisotopic Mass622.15338 Da
IUPAC Name[(2S,3R,4R,5S)-5-{[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-6-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4H-chromen-3-yl]oxy}-3,4-dihydroxyoxolan-2-yl]methyl acetate
Traditional Name[(2S,3R,4R,5S)-5-{[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-6-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-3-yl]oxy}-3,4-dihydroxyoxolan-2-yl]methyl acetate
CAS Registry NumberNot Available
SMILES
C[C@@H]1O[C@@H](OC2=CC=C3OC(C4=CC=C(O)C(O)=C4)=C(O[C@@H]4O[C@@H](COC(C)=O)[C@H](O)[C@H]4O)C(=O)C3=C2O)[C@H](O)[C@H](O)[C@H]1O
InChI Identifier
InChI=1S/C28H30O16/c1-9-18(32)22(36)24(38)27(40-9)42-15-6-5-14-17(19(15)33)21(35)26(25(41-14)11-3-4-12(30)13(31)7-11)44-28-23(37)20(34)16(43-28)8-39-10(2)29/h3-7,9,16,18,20,22-24,27-28,30-34,36-38H,8H2,1-2H3/t9-,16-,18-,20-,22+,23+,24+,27-,28-/m0/s1
InChI KeyFQWPUSFOXKIWJB-JZHHZRDPSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of OriginNot Available
Chemical Taxonomy
Description Belongs to the class of organic compounds known as flavonoid-3-o-glycosides. These are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C3-position.
KingdomOrganic compounds
Super ClassPhenylpropanoids and polyketides
ClassFlavonoids
Sub ClassFlavonoid glycosides
Direct ParentFlavonoid-3-O-glycosides
Alternative Parents
Substituents
  • Flavonoid-3-o-glycoside
  • Hydroxyflavonoid
  • Flavone
  • 5-hydroxyflavonoid
  • 4'-hydroxyflavonoid
  • 3'-hydroxyflavonoid
  • Phenolic glycoside
  • O-glycosyl compound
  • Glycosyl compound
  • Chromone
  • 1-benzopyran
  • Benzopyran
  • Catechol
  • 1-hydroxy-4-unsubstituted benzenoid
  • 1-hydroxy-2-unsubstituted benzenoid
  • Pyranone
  • Phenol
  • Benzenoid
  • Pyran
  • Oxane
  • Monosaccharide
  • Monocyclic benzene moiety
  • Heteroaromatic compound
  • Vinylogous acid
  • Tetrahydrofuran
  • Secondary alcohol
  • Carboxylic acid ester
  • Oxacycle
  • Organoheterocyclic compound
  • Polyol
  • Monocarboxylic acid or derivatives
  • Carboxylic acid derivative
  • Acetal
  • Organic oxygen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organooxygen compound
  • Carbonyl group
  • Alcohol
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP-0.29ChemAxon
pKa (Strongest Acidic)7.54ChemAxon
pKa (Strongest Basic)-3.6ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count15ChemAxon
Hydrogen Donor Count8ChemAxon
Polar Surface Area251.36 ŲChemAxon
Rotatable Bond Count8ChemAxon
Refractivity143.07 m³·mol⁻¹ChemAxon
Polarizability59.46 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound102516584
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Agarwal K, Saikia P, Podder I: Metabolic syndrome and Dyslipidemia in xanthelasma palpebrarum and associated risk-factors- a case-control study. J Cosmet Dermatol. 2022 Sep 3. doi: 10.1111/jocd.15353. [PubMed:36057448 ]
  2. Rashid N, Krakow EF, Yeh A, Oshima MU, Onstad L, Connelly-Smith L, Vo P, Mielcarek M, Lee SJ: Late effects of severe acute GVHD on quality of life, medical comorbidities and survival. Transplant Cell Ther. 2022 Aug 31. pii: S2666-6367(22)01594-9. doi: 10.1016/j.jtct.2022.08.027. [PubMed:36057421 ]
  3. Castellanos-Ortega A, Broch MJ, Palacios-Castaneda D, Gomez-Tello V, Valdivia M, Vicent C, Madrid I, Martinez N, Parraga MJ, Sancho E, Fuentes-Dura MDC, Sancerni-Beitia MD, Garcia-Ros R: Competency assessment of residents of Intensive Care Medicine through a simulation-based objective structured clinical evaluation (OSCE). A multicenter observational study. Med Intensiva (Engl Ed). 2022 Sep;46(9):491-500. doi: 10.1016/j.medine.2022.01.001. [PubMed:36057440 ]
  4. Ogawa A, Kojima F, Miyake Y, Yoshimura M, Ishijima N, Iyoda S, Sekine Y, Yamanaka Y, Yamamoto K: Regulation of constant cell elongation and Sfm pili synthesis in Escherichia coli via two active forms of FimZ orphan response regulator. Genes Cells. 2022 Nov;27(11):657-674. doi: 10.1111/gtc.12982. Epub 2022 Sep 18. [PubMed:36057789 ]
  5. Liu Q, Palmgren VAC, Danen EH, Le Devedec SE: Acute vs. chronic vs. intermittent hypoxia in breast Cancer: a review on its application in in vitro research. Mol Biol Rep. 2022 Nov;49(11):10961-10973. doi: 10.1007/s11033-022-07802-6. Epub 2022 Sep 3. [PubMed:36057753 ]
  6. Ebenau JL, Visser D, Kroeze LA, van Leeuwenstijn MSSA, van Harten AC, Windhorst AD, Golla SVS, Boellaard R, Scheltens P, Barkhof F, van Berckel BNM, van der Flier WM: Longitudinal change in ATN biomarkers in cognitively normal individuals. Alzheimers Res Ther. 2022 Sep 3;14(1):124. doi: 10.1186/s13195-022-01069-6. [PubMed:36057616 ]
  7. Beogo I, Bationo NJ, Sia D, Collin S, Kinkumba Ramazani B, Letourneau AA, Ramde J, Gagnon MP, Tchouaket EN: COVID-19 pandemic or chaos time management: first-line worker shortage - a qualitative study in three Canadian Provinces. BMC Geriatr. 2022 Sep 3;22(1):727. doi: 10.1186/s12877-022-03419-3. [PubMed:36057549 ]
  8. Chakraborty S, Bhattacharjee S, Tiwari B, Jaishwal T, Singh SS, Mishra AK: Deciphering the mechanisms of zinc tolerance in the cyanobacterium Anabaena sphaerica and its zinc bioremediation potential. Environ Sci Pollut Res Int. 2023 Jan;30(4):9591-9608. doi: 10.1007/s11356-022-22388-z. Epub 2022 Sep 3. [PubMed:36057058 ]
  9. Chi Z, Ju S, Liu X, Sun F, Zhu Y: Graphene oxide supported sulfidated nano zero-valent iron (S-nZVI@GO) for antimony removal: The role of active oxygen species and reaction mechanism. Chemosphere. 2022 Dec;308(Pt 1):136253. doi: 10.1016/j.chemosphere.2022.136253. Epub 2022 Aug 31. [PubMed:36057347 ]
  10. Larsen MB, Hedelund M, Flander L, Andersen B: The impact of pre-notifications and reminders on participation in colorectal cancer screening - A randomised controlled trial. Prev Med. 2022 Nov;164:107229. doi: 10.1016/j.ypmed.2022.107229. Epub 2022 Aug 31. [PubMed:36057390 ]
  11. Hui Z, Chang M, Hu M: Sensitive analysis of pneumonia related small extracellular vesicles (sEVs) through Exo-III assisted catalytic DNA amplification. Anal Biochem. 2022 Nov 1;656:114875. doi: 10.1016/j.ab.2022.114875. Epub 2022 Aug 31. [PubMed:36057365 ]
  12. Cho SH, Lim KH: Conservative treatment of blunt traumatic right renal venous pseudoaneurysm: A case report. Int J Surg Case Rep. 2022 Sep;98:107572. doi: 10.1016/j.ijscr.2022.107572. Epub 2022 Aug 31. [PubMed:36057247 ]
  13. Wang Q, Zhang M, Li R, Jiang XT: Does marine environmental research meet the challenges of marine pollution induced by the COVID-19 pandemic? Comparison analysis before and during the pandemic based on bibliometrics. Mar Pollut Bull. 2022 Oct;183:114046. doi: 10.1016/j.marpolbul.2022.114046. Epub 2022 Aug 15. [PubMed:36057155 ]
  14. Alderuccio JP, Reis IM, Habermann TM, Link BK, Thieblemont C, Conconi A, Larson MC, Cascione L, Zhao W, Cerhan JR, Zucca E, Lossos IS: Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma. Am J Hematol. 2022 Dec;97(12):1529-1537. doi: 10.1002/ajh.26715. Epub 2022 Sep 19. [PubMed:36057138 ]
  15. Bello AA, Renai J, Hassan A, Akadiri SS, Itari AR: Synergy effects of ICT diffusion and foreign direct investment on inclusive growth in Sub-Saharan Africa. Environ Sci Pollut Res Int. 2023 Jan;30(4):9428-9444. doi: 10.1007/s11356-022-22689-3. Epub 2022 Sep 3. [PubMed:36057065 ]
  16. LOTUS database [Link]